Clobetasolo Pierre Fabre Italia Uses, Dosage, Side Effects and more
Clobetasolo Pierre Fabre Italia is under investigation for the treatment of Scleroderma. Clobetasolo Pierre Fabre Italia has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetasolo Pierre Fabre Italia |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Italy |
| Last Updated: | January 7, 2025 at 1:49 am |
Clobetasolo Pierre Fabre Italia Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
